Disclosures for "Late onset myopathy related to CACNA1S mutation: expanding the phenotype."
-
Dr. Ahmed has nothing to disclose.
-
Dr. Mnatsakanova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. Dr. Mnatsakanova has received research support from Mitsubishi .
-
Dr. Paul has nothing to disclose.